P419: Proximal Crohn’s disease location is associated with a more benign course of perianal Crohn’s disease (the PERIAPROX study)ECCO'24Year: 2024
Authors: Romero-Mascarell, C.(1);Giordano, A.(1)*;Riestra, S.(2);Martín-Arranz, M.D.(3);Ricart, E.(4);Gisbert, J.P.(5);Brunet-Mas, E.(6);Rivas Rivas, C.(7);Calafat, M.(8);Fernández Salgado, E.(9);Guardiola, J.(10);Gomollón, F.(11);Sierra Moros, E.(12);Hernández Camba, A.(13);Iglesias, E.(14);De Prado, Á.(15);Martinez-Montiel, P.(16);Mesonero, F.(17);Varela, P.(18);de Castro, L.(19);Madero Velázquez, L.(20);Lázaro Pérez-Calle, J.(21);Esteve , M.(22);Rodríguez-Lago, I.(23);Bermejo, F.(24);Lorente , R.(25);Sicilia, B.(26);Castro-Poceiro, J.(27);Gordillo, J.(1);Huguet, J.M.(28);Ponferrada , A.(29);Sierra , M.(30);Bujanda, L.(31);Marín-Jiménez, I.(32);Pascual, I.(33);Vera, I.(34);Sesé, E.(35);Vega, P.(36);Domènech, E.(8);Garcia-Planella, E.(1);
(1)Hospital de la Santa Creu i Sant Pau, Gastroenterology Department, Barcelona, Spain;(2)Hospital Universitario Central de Asturias- and Instituto de Investigación Sanitaria del Principado de Asturias ISPA, Gastroenterology Department, Oviedo, Spain;(3)Hospital Universiario La Paz, Gastroenterology Department, Madrid, Spain;(4)Hospital Clínic. Institut d@E@Investigacions Biomèdiques August Pi i Sunyer IDIBAPS. Centro de Investigación Biomédica en RED CIBEREHD, Gastroenterology Department., Barcelona, Spain;(5)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-Princesa- Universidad Autónoma de Madrid UAM- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD., Gastroenterology Department, Madrid, Spain;(6)Parc Taulí- Hospital Universitari. Institut d@E@Investigació i Innovació Parc Taulí. Departament de Medicina. Universitat Autònoma de Barcelona. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Gastroenterology Department, Sabadell, Spain;(7)Hospital Universitario Marqués de Valdecilla e IDIVAL, Gastroenterology Department, Santander, Spain;(8)Hospital Universitari Germans Trias i Pujol. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Gastroenterology Department, Badalona, Spain;(9)Complexo Hospitlario Universitario de Pontevedra., Gastroenterology Department, Pontevedra, Spain;(10)Hospital Universitari Bellvitge, Gastroenterology Department, L@E@Hospitalet de Llobregat., Spain;(11)Hospital Clínico Lozano Blesa. Instituto de investigación sanitaria de Aragón IIS. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Gastroenterology Department, Zaragoza, Spain;(12)Hospital Universitario Miguel Servet. Instituto de investigación sanitaria de Aragón IIS, Gastroenterology Department, Zaragoza, Spain;(13)Hospital Universitario Nuestra Sra. de la Candelaria, Gastroenterology Department, Santa Cruz de Tenerife, Spain;(14)Hospital Universitario Reina Sofía, Gastroenterology Department, Córdoba, Spain;(15)Hospital Universitario Río Hortega, Gastroenterology Department, Valladolid, Spain;(16)Hospital 12 de Octubre, Gastroenterology Department, Madrid, Spain;(17)Hospital Universitario Ramón y Cajal, Gastroenterology Department, Madrid, Spain;(18)Hospital Universitario de Cabueñes, Gastroenterology Department, Gijón, Spain;(19)Hospital Álvaro Cunqueiro, Gastroenterology Department, Vigo, Spain;(20)Hospital General Universitario Dr Balmis e ISABIAL. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Gastroenterology Department, Alicante, Spain;(21)Hospital Universitario Fundación de Alcorcón, Gastroenterology Department, Alcorcón, Spain;(22)Hospital Universitari Mútua Terrassa. University of Barcelona. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Gastroenterology Department, Terrassa, Spain;(23)Hospital de Galdakao, Gastroenterology Department, Galdakao, Spain;(24)Hospital de Fuenlabrada, Gastroenterology Department, Fuenlabrada, Spain;(25)Hospital General Universitario de Ciudad Real, Gastroenterology Department, Ciudad Real, Spain;(26)Hospital Universitario de Burgos, Gastroenterology Department, Burgos, Spain;(27)Hospital Moisès Broggi, Gastroenterology Department, Sant Joan Despí, Spain;(28)Hospital General Universitario de Valencia, Gastroenterology Department, Valencia, Spain;(29)Hospital Universitario Infanta Leonor, Gastroenterology Department, Madrid, Spain;(30)Complejo Asistencial Universitario de León, Gastroenterology Department, León, Spain;(31)Biodonostia Health Research Institute. Universidad del País Vasco UPV/EHU. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Gastroenterology Department, San Sebastián, Spain;(32)IiSGM- Hospital Gregorio Marañón- Medicine Faculty- Complutense University- Madrid, Gastroenterology Department, Madrid, Spain;(33)Hospital Clínico de Valencia, Gastroenterology Department, Valencia, Spain;(34)Hospital Universitario Puerta de Hierro, Gastroenterology Department, Majadahonda, Spain;(35)Hospital Universitari Arnau de Vilanova, Gastroenterology Department, Lleida, Spain;(36)Complexo H. Universitario de Ourense, Gastroenterology Department, Ourense, Spain;
P420: Natural history of intra-abdominal inflammatory masses (phlegmons) in Crohn’s diseaseECCO'24Year: 2024
Authors: Djalal, A.(1)*;Sehgal, P.(2);Shenoy, S.(1);Benson, C.(1);Rajauria, P.(1);Agrawal, M.(1);Colombel, J.F.(1);Lewis, J.(2);Ungaro, R.(1);
(1)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States;(2)University of Pennsylvania Health System, Gastroenterology, Philadelphia, United States;
P421: The faecal biomarker LDN-051 is a novel tool for monitoring disease activity and therapeutic response in Inflammatory Bowel DiseasesECCO'24Year: 2024
Authors: Jójárt, B.(1,2,3,4)*;Resál, T.(4);Diána, K.(5);Molnár, T.(3,4);Bacsur, P.(4);Szabó, V.(2,3,4);Varga, Á.(2,3,4);Szántó, K.J.(4);Pallagi, P.(1,2,3,4);Földesi, I.(5);Molnár, T.(4);Maléth, J.(1,2,3,4);Farkas, K.(4);
(1)Ladon Therapeutics Ltd, Ladon Therapeutics Ltd, Szeged, Hungary;(2)HCEMM-USz, Molecular Gastroenterology Research Group, Szeged, Hungary;(3)University of Szeged, ELKH-USZ Momentum Epithelial Cell Signaling and Secretion Research Group, Szeged, Hungary;(4)University of Szeged, Szent-Györgyi Albert Medical School- Department of Medicine, Szeged, Hungary;(5)University of Szeged, Szent-Györgyi Albert Medical School- Institute of Laboratory Medicine, Szeged, Hungary;HCEMM-USz Molecular Gastroenterology Research Group
P422: Prevalence of poor sleep quality assessed by wrist actigraphy and sleep questionnaire in Inflammatory Bowel Disease patients and its association with disease activity and quality of lifeECCO'24Year: 2024
Authors: Chaemsupaphan, T.(1)*;Subdee, N.(1);Phaophu, P.(1);Salaemae, M.(1);Permpim, P.(1);Wannasewok, K.(2);Pimolsri, C.(3);Chotinaiwattarakul, W.(3);Limsrivilai, J.(1);
(1)Siriraj Hospital Mahidol University, Gastroenterology, Bangkok, Thailand;(2)Siriraj Hospital Mahidol University, Psychiatry, Bangkok, Thailand;(3)Siriraj Hospital Mahidol University, Siriraj Sleep Center, Bangkok, Thailand;
P423: Incidence of Colorectal Cancer among Patients with Ulcerative Colitis in the Middle East: A Systematic Review and Meta-AnalysisECCO'24Year: 2024
Authors: Alshahrani, A.(1)*;
(1)NA, Internal Medicine, Najran, Saudi Arabia;Abdulaziz S. Alshahrani Ahmad A. Albdrani Turki Alamri Mariam S. Mukhtar
P424: Analysis of the intestinal microbiome using an Endoscopic Brush in Ulcerative colitisECCO'24Year: 2024
Authors: Lee, B.(1)*;Keum, B.(1);Kim, S.(1);Jeon, H.(1);Jeen, Y.(1);Hoonjai, C.(1);
(1)Korea University Anam Hospital, Division of Gastroenterology and Hepatology- Department of Internal Medicine, Seoul, Korea- Republic Of;
P425: Clinical Characteristics of Steroid-Dependent Ulcerative Colitis Patients after Acute Severe Ulcerative Colitis Treatment in East Asia and Australia/New Zealand: AOCC and ANZIBDC collaboration studyECCO'24Year: 2024
Authors: Kim, D.H.(1,2)*;Park, S.H.(2,3);Kim, H.S.(4);Kim, S.J.(5);Kim, K.O.(2,6);Lee, Y.J.(2,7);Song, E.M.(2,8);Kim, E.S.(2,9);Lee, H.S.(9);An, Y.K.(10,11);Begun, J.(10,11);Ruddick-Collins, L.(11,12);Fernandes, R.(10);Liu, J.(13);Cao, Q.(13);Kobayashi, T.(14);Wei, S.C.(15);
(1)Chonnam National University Hospital, Department of Internal Medicine- Division of Gastroenterology, Gwnagju, Korea- Republic Of;(2)IBD Research Group, Korean Association for the Study of the Intestinal Diseases KASID, Seoul, Korea- Republic Of;(3)University of Ulsan College of Medicine- Asan Medical Center, Department of Gastroenterology and Inflammatory Bowel Disease Center, Seoul, Korea- Republic Of;(4)Chonnam National University Hospital, Department of Internal Medicine- Division of Gastroenterology, Gwangju, Korea- Republic Of;(5)Chosun University Hospital, Department of Internal Medicine- Division of Gastroenterology, Gwangju, Korea- Republic Of;(6)Yeungnam University Hospital, Department of Internal Medicine- Division of Gastroenterology, Daegu, Korea- Republic Of;(7)Keimyung University Hospital, Department of Internal Medicine- Division of Gastroenterology, Daegu, Korea- Republic Of;(8)Ewha Womans University Seoul Hospital, Division of Gastroenterology- Department of Internal Medicine, Seoul, Korea- Republic Of;(9)Kyungpook National University Hospital, Department of Internal Medicine- Division of Gastroenterology, Daegu, Korea- Republic Of;(10)Mater Hospital, Department of Gastroenterology, Brisbane, Australia;(11)ANZIBDC, Australia New Zealand IBD Consortium, Brisbane, Australia;(12)University of Queensland, Mater Research Institute, Brisbane, Australia;(13)Zhejiang Chinese Medical University, School of Life Science, Hangzhou, China;(14)Kitasato University Kitasato Institute Hospital, Center for Advanced IBD Research and Treatment, Tokyo, Japan;(15)National Taiwan University Hospital- National Taiwan University, Department of Internal Medicine, Taipei, Taiwan;
P426: Hematological Composite Scores in Patients with Inflammatory Bowel DiseaseECCO'24Year: 2024
Authors: Morant-Domínguez, A.(1);Vera-Santana, B.(1);Hernández-Camba, A.(2);Ramos, L.(1);Alonso-Abreu, I.(1);Hernández Álvarez-Buylla, N.(1);Vela, M.(2);Hernández-Guerra, M.(1);Laura , A.(1);Ferraz-Amaro, I.(3);Carrillo Palau, M.(1)*;
(1)Hospital Universitario de Canarias, Gastroenterology, Santa Cruz de Tenerife, Spain;(2)Hospital Universitario de Nuestra Señora de la Candelaria, Gastroenterology, Santa Cruz de Tenerife, Spain;(3)Hospital Universitario de Canarias, Reumatology, Santa Cruz de Tenerife, Spain;
P427: Inflammatory bowel disease after liver transplantation: a retrospective cohort study from Latin AmericaECCO'24Year: 2024
Authors: Penna, F.G.C.E.(1);Bayma, L.R.(2);Azzi, L.L.M.(1);Faria, A.A.D.(1);Campos, J.F.(1);Ferrari, M.D.L.D.A.(1);Daguer, F.B.R.(1);Azevedo, M.F.C.D.(2);Carlos, A.D.S.(2);Cançado, E.L.R.(2);Terrabuio, D.R.B.(2);Damião, A.O.M.C.(2);Barros, L.L.(2)*;
(1)Federal University of Minas Gerais, Gastroenterology and Hepatology, Belo Horizonte, Brazil;(2)University of São Paulo School of Medicine, Gastroenterology and Hepatology, São Paulo, Brazil;
P428: Nutritional, Muscular status and micronutrient deficiencies in patients with Inflammatory Bowel DiseaseECCO'24Year: 2024
Authors: Han, J.(1)*;Song, H.J.(1);Kim, H.U.(1);Kang, M.S.(2);Kang, K.S.(3);
(1)Jeju national university hospital, Department of Internal medicine, Jeju city, Korea- Republic Of;(2)Jeju national university hospital, Department of Food and Nutrition Service Team, Jeju city, Korea- Republic Of;(3)Jeju national university hospital, Department of Pediatrics, Jeju city, Korea- Republic Of;
P429: Explainable AI identified metabolome and diet interactions in the blood and faceal samplesECCO'24Year: 2024
Authors: Acharjee, A.(1)*; Onwuka, S.(2);Bravo, L.(1);Gkoutos, G.(1);
(1)University of Birmingham, Institute of Cancer and Genomic Sciences, Birmingham, United Kingdom;(2)University of Birmingham, Institute of Cancer and Genomic Sciences, Birmingham, United Arab Emirates;
P430: The influence of persistent organ damage on IFX pharmacokinetic modeling and disease progression assessment: findings from a prospective real-world study in inflammatory bowel disease patientsECCO'24Year: 2024
Authors: Magro, F.(1,2,3,4,5)*;Fernandes, S.(6,7);Patita, M.(8);Arroja, B.(9);Lago, P.(2,10);Rosa, I.(11);Tavares de Sousa, H.(12,13);Ministro, P.(2,14);Mocanu, I.(8);Vieira, A.(8);Castela, J.(15);Moleiro, J.(15);Roseira, J.(12,13);Cancela, E.(14);Sousa, P.(14);Portela, F.(2,16);Correia, L.(2,17);Moreira, P.(3);Afonso, J.(2);Dias, S.(2);Danese, S.(18,19);Peyrin-Biroulet, L.(20);Vucicevic, K.(21);Santiago, M.(2);
(1)São João Hospital University Center, Gastroenterology Department, Porto, Portugal;(2)Portuguese Group of Studies in Inflammatory Bowel Disease, Gedii, Porto, Portugal;(3)São João Hospital University Center, Clinical Pharmacology Unit, Porto, Portugal;(4)Faculty of Medicine- University of Porto, Centre for Health Technology and Services Research- Health Research Network CINTESIS@RISE, Porto, Portugal;(5)Faculty of Medicine- University of Porto, Department of Biomedicine- Unit of Pharmacology and Therapeutics, Porto, Portugal;(6)Northern Lisbon University Center, Gastroenterology Department, Lisbon, Portugal;(7)Medical University of Lisbon, Clinica Universitária de Gastrenterologia, Lisbon, Portugal;(8)Garcia da Orta Hospital, Gastroenterology Department, Lisbon, Portugal;(9)Braga Hospital, Gastroenterology Department, Braga, Portugal;(10)Porto Hospital University Center, Gastroenterology Department, Porto, Portugal;(11)IPOLFG, Gastroenterology Department, Lisboa, Portugal;(12)Algarve Hospital University Center ‐ Portimão Unit, Gastroenterology Department, Portimão, Portugal;(13)University of Algarve, ABC - Algarve Biomedical Center, Faro, Portugal;(14)Viseu‐Tondela Hospital Center, Gastroenterology Department, Viseu, Portugal;(15)IPOLFG, Gastroenterology Department, Lisbon, Portugal;(16)Coimbra Hospital University Center, Gastroenterology Department, Coimbra, Portugal;(17)Northern Lisbon University Hospital Center, Gastroenterology Department, Lisbon, Portugal;(18)Humanitas University, Department of Biomedical Sciences, Milan, Italy;(19)Humanitas Research Hospital- IRCCS, IBD Center, Milan, Italy;(20)University Hospital of Nancy- University of Lorraine, Department of Gastroenterology and Inserm NGERE U1256, Nancy, France;(21)University of Belgrade, Department of Pharmacokinetics and Clinical Pharmacy, Belgrade, Serbia;
P431: Assessing intestinal barrier healing by fusing ultra-high magnification endoscope and automated spatial multispectral imaging analysis in PSC-colitis patientsECCO'24Year: 2024
Authors: Iacucci, M.(1,2,3)*;Majumder, S.(1,3);Santacroce, G.(1);Zammarchi, I.(1);Maeda, Y.(1);Shivaji, U.N.(2,3);Abdawn, Z.(4);Hejmadi, R.(4);Hayes, B.(5);Crotty, R.(5);Burke, L.(5);Ghosh, S.(1);
(1)APC Microbiome Ireland-College of Medicine and Health, University College of Cork, Cork, Ireland;(2)Gastroenterology-Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom;(3)Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom;(4)Department of Histopathology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom;(5)Department of Histopathology, Cork University Hospital, Cork, Ireland;
P432: Real-time automated assessment of histological disease activity in patients with ulcerative colitis using single wavelength endoscopy technologyECCO'24Year: 2024
Authors: Sinonquel, P.(1,2)*;Lenfant, M.(1,2);Eelbode, T.(3);Callaerts, B.(3);Watanabe, H.(4);Guedelha Sabino, J.P.(1,2);Verstockt, B.(1,2);Maes, F.(3);De Hertogh, G.(5);Vermeire, S.(1,2);Bisschops, R.(1,2);
(1)UZ Leuven, Gastroenterology and Hepatology, Leuven, Belgium;(2)KU Leuven, Translational Research in Gastrointestinal Disorders, Leuven, Belgium;(3)KU Leuven, Electrical Engineering ESAT/PSI, Leuven, Belgium;(4)Fujifilm, Medical Systems R&D Center-, Tokyo, Japan;(5)UZ Leuven, Pathology, Leuven, Belgium;
P433: Short-term outcomes of surgical treatment in primary ileocecal Crohn’s disease patients. Results of Crohn’s(urg) study, multicenter, retrospective, comparative analysis between indications for luminal and complicated phenotype.ECCO'24Year: 2024
Authors: Avellaneda, N.L.(1)*;Pellino, G.(2);Maroli, A.(3);Tottrup, A.(4);Bislenghi, G.(5);Colpaert, J.(5);D@E@Hoore, A.(5);Giorgi, L.(3);Juachon, P.(3);Harsløf, S.(4);de Buck Van Overstraeten, A.(6);Olivera, P.(6);Gomez, J.(6);Holubar, S.(7);Lincango Naranjo, E.(7);Steele, S.(7);Merchea, A.(8);Shacker, A.(8);Marti Gallostra, M.(9);Kraft, M.(9);Kotze, P.G.(10);Yuki Maruyana, B.(10);Wexner, S.(11);Garoufalia, Z.(11);Zhihui, C.(12);Hahnloser, D.(13);Rrupa, D.(13);Buskens, C.(14);Haanappel , A.(15);Warusavitarne, J.(16);Williams, K.(16);Christensen, P.(4);Spinelli, A.(3);
(1)Aarhus University Hospital- Denmark, Colorectal Surgery, Capital Federal, Argentina;(2)Università degli Studi della Campania @D@Luigi Vanvitelli@D@, Advanced Medical and Surgical Sciences, Naples, Italy;(3)Humanitas Research Hospital, Colorectal Surgery, Milan, Italy;(4)Aarhus University Hospital, Colorectal Surgery, Aarhus, Denmark;(5)Leuven University Hospital, Colorectal Surgery, Leuven, Belgium;(6)Sinai Health Hospital, Colorectal Surgery, Toronto, Canada;(7)Cleveland Clinic, Colorectal Surgery, Ohio, United States;(8)Mayo Clinic, Colorectal Surgery, Jacksonville, United States;(9)Vall d@E@Hebron University Hospital, Colorectal Surgery, Barcelona, Spain;(10)Pontifícia Universidade Católica do Paraná PUCPR, Colorectal Surgery, Curitiba, Brazil;(11)Cleveland Clinic, Colorectal Surgery, Florida, United States;(12)Sun Yat-sen University, Colorectal Surgery, China, China;(13)Lausanne University Hospital, Colorectal Surgery, Lausanne, Switzerland;(14)Amsterdam Medical Hospitals, Colorectal Surgery, Amsterdam, The Netherlands;(15)Amsterdam Medical Hospital, Colorectal Surgery, Amsterdam, The Netherlands;(16)San Marks Hospital, Colorectal Surgery, London, United Kingdom;
P434: Incidence of chronic end-stage renal disease in patients with inflammatory bowel disease: a population-based cohort study from the French National Health Insurance Database.ECCO'24Year: 2024
Authors: Prothe, C.(1)*;Boitel, A.(2);Martin, B.(2);Clairet, V.(3);Juif, L.(3);Lang, S.(4);Koch, S.(3);Ducloux, D.(4,5);Desmarets, M.(6,7);Vuitton, L.(3,5);
(1)CHU JMinjoz, service de gastroentérologie, Besancon, France;(2)CHU JMinjoz, Inserm- Centre d’investigation clinique 1431, Besançon, France;(3)CHU JMinjoz, Service de gastroentérologie, Besançon, France;(4)CHU JMinjoz, service de néphrologie, Besançon, France;(5)Université de Franche Comté, EFS- Inserm- UMR Right-, Besançon, France;(6)CHU JMinjoz, Inserm- Centre d’investigation clinique 1431-, Besançon, France;(7)Université de Franche-Comté, EFS- Inserm- UMR Right, Besançon, France;
P435: Plasma inflammation-related proteins as markers of anxiety and depression disorders in inflammatory bowel disease patientsECCO'24Year: 2024
Authors: Zhou, M.S.(1)*;Dang, Y.(1);Xu, F.(1);Xu, C.Y.(1);Wang, Z.(1);Wang, C.S.E.(1);Zhu, S.Y.(1);Li, P.(1);Wu, J.(1);Shi, H.Y.(1);
(1)Capital Medical University- Beijing Friendship Hospital- National Clinical Research Center for Digestive Diseases, Department of gastroenterology, Beijing, China;
P436: The AI based Red Density score is correlated with the established and new histological indices for Ulcerative Colitis in an independent cohort.ECCO'24Year: 2024
Authors: BossuytMD PhD, P.(1)*;Sinonquel, P.(2);John, S.(3);Shivaji, U.(4);Iacucci, M.(5);Nakase, H.(6);Van Aelst, S.(7);Pillai, S.(8);Abdawn, Z.(9);Sugita, S.(10);McCartney, S.(11);Armuzzi, A.(12);Bessissow, T.(13);Rath, T.(14);Yang, D.H.(15);Vermeire, S.(2);De Hertogh, G.(16);Bisschops, R.(2);
(1)Imelda General Hospital, Department of Gastroenterology, Bonheiden, Belgium;(2)UZ Leuven, Department of gastroenterology, Leuven, Belgium;(3)Gold Coast University Hospital, Department of gastroenterology, Gold Coast, Australia;(4)University Hospital Birmingham, Department of gastroenterology, Birmingham, United Kingdom;(5)University Hospital Cork, Department of gastroenterology, Cork, Ireland;(6)Sapporo Medical University, Department of gastroenterology, Sapporo, Japan;(7)Imelda General Hospital, Department of pathology, Bonheiden, Belgium;(8)Gold Coast University Hospital, Department of pathogology, Gold Coast, Australia;(9)University Hospital Birmingham, Department of pathology, Birmingham, United Kingdom;(10)Sapporo Medical University, Department of pathology, Sapporo, Japan;(11)University College London, Department of gastroenterology, London, United Kingdom;(12)Huminatas University Hospital, Department of gastroenterology, Milan, Italy;(13)McGill University Health Center, Department of gastroenterology, Montreal, Canada;(14)University Hospitals Erlangen, Department of gastroenterology, Erlangen, Germany;(15)Asan Medical Center, Department of gastroenterology, Seoul, Korea- Republic Of;(16)UZ Leuven, Department of pathology, Leuven, Belgium;
P437: Feasibility study of a Point-of-Care assay for rapid determination of anti-TNFα biologics in capillary bloodECCO'24Year: 2024
Authors: Ricken, B.(1)*;Brosi, L.(1);Reinhard, C.(2);Anchling, L.(2);Neu, S.(3);Afonso, J.(1);Schuster, T.(4);Wütherich, E.(5);Burri, E.(5);Paul, S.(6);Berger, A.E.(6);Guirao, W.(7);Barrau, M.(7);Bastide, L.(7);Roblin, X.(7);Pflimlin-Fritschy, V.(8);Rutscher, U.(9);Hrúz, P.(8);Gerhold, C.B.(10);
(1)BÜHLMANN Laboratories AG, POC & ST Development, Schönenbuch, Switzerland;(2)BÜHLMANN Laboratories AG, POC & ST Marketing, Schönenbuch, Switzerland;(3)BÜHLMANN Laboratories AG, Regulatory Affairs, Schönenbuch, Switzerland;(4)BÜHLMANN Laboratories AG, Validation, Schönenbuch, Switzerland;(5)Kantonsspital Baselland, Gastroenterology and Hepatology, Liestal, Switzerland;(6)University Hospital of Saint-Etienne, Immunology laboratory- iBiothera reference center- CIC1408, Saint-Etienne, France;(7)Centre Hospitalier Universitaire de Saint-Étienne, Gastro-entérologie et Hépatologie maladies inflammatoires, Saint-Etienne, France;(8)Clarunis, Gastroenterology/Hepatology, Basel, Switzerland;(9)Claunis, Gastroenterology/Hepatology, Basel, Switzerland;(10)BÜHLMANN Laboratories AG, Development, Schönenbuch, Switzerland;
P438: Histological scores are poor predictors of short-term response to therapy in acute severe ulcerative colitisECCO'24Year: 2024
Authors: Jena, A.(1)*;Mishra, S.(1);Sekar, A.(2);Prasad, K.K.(1);Sachan, A.(1);Singh, A.K.(1);Shah, J.(1);Mandavdhare, H.S.(1);Singh, H.(3);Dutta, U.(1);Sharma, V.(1);
(1)Post Graduate Institute of Medical Education and Research, Gastroenterology, Chandigarh, India;(2)Post Graduate Institute of Medical Education and Research, Histopathology, Chandigarh, India;(3)Post Graduate Institute of Medical Education and Research, Surgical Gastroenterology, Chandigarh, India;